StonvexLoading…
StonvexStonvexStonvexCore line items from PGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.68M | $3.92M | $6.22M | $26.91M |
Operating Income | $-110.51M | $-135.03M | $-99.76M | $-79.97M |
Net Income | $-250.64M | $-126.23M | $-95.90M | $28.32M |
EPS (Diluted) | $-1.37 | $-0.47 | $-0.39 | $0.14 |
Total Assets | $155.50M | $145.27M | $151.04M | $215.98M |
Total Liabilities | $134.59M | $78.53M | $32.55M | $89.72M |
Cash & Equivalents | $30.23M | $29.52M | $7.58M | $4.86M |
Free Cash Flow OCF − CapEx | $-89.83M | $-76.76M | $-68.47M | $-69.97M |
Shares Outstanding | 353.91M | 292.87M | 248.92M | 208.15M |